Neonc Technologies logo
Neonc Technologies
NTHI | NASDAQ
Chart Builder DCF Calculator
$4.54
-$0.37 (-7.54%)
At close: Nov 16, 2026, 4:00 PM ET
$4.47
-$0.07 (-1.54%)
After-hours: Nov 16, 2026, 7:57 PM ET

Neonc Technologies Company Profile

Company profile explained

Company Profile

NeOnc Technologies Holdings, Inc. is a clinical-stage biopharmaceutical company. It develops novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. The company was founded in 2008 and is headquartered in Calabasas, CA.

Key Executives

Name Position
Amir Farrokh Heshmatpour President, Chief Executive Officer, Executive Chairman & Secretary
Keithly A. Garnett Chief Financial Officer
David Choi Chief Accounting Officer
Josh Neman-Ebrahim Chief Clinical Officer
Thomas C. Chen Founder, Chief Medical Officer, Chief Scientific Officer & Vice Chairman

Latest SEC Filings

Date Type Title
Oct 22, 2026 8-K Current Report
Oct 15, 2026 3 Filing
Oct 15, 2026 8-K Current Report
Sep 28, 2026 8-K Current Report
Sep 21, 2026 8-K Current Report
Sep 18, 2026 4 Filing
Sep 17, 2026 8-K Current Report
Sep 15, 2026 4 Filing
Sep 15, 2026 4 Filing
Sep 15, 2026 4 Filing
View All SEC Filings ➞
Neonc Technologies
Neonc Technologies logo
Country United States
IPO Date Mar 26, 2025
Industry Biotechnology
Sector Healthcare
Employees 5
CEO Amir Farrokh Heshmatpour

Contact Details

23975 Park Sorrento Calabasas, California 91302 United States

Stock Details

Ticker Symbol NTHI
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001979414
CUSIP Number 64051A101
ISIN Number US64051A1016
SIC Code 2834

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.